Brief: Noxopharm Says Noxcovid Clinical Program To Expand Following Positive Phase 1 Clinical Results
23/08/2021 02:19
Aug 23 (Reuters) - Noxopharm Ltd NOX.AX :
* NOXOPHARM- NOXCOVID CLINICAL PROGRAM TO EXPAND FOLLOWING
POSITIVE PHASE 1 CLINICAL RESULTS
Source text for Eikon: ID:nASX9ZJNlc
Further company coverage: NOX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Noxopharm
See all newsBrief: Noxopharm Announces SOF-SKN Manufacturing Begins To Ensure Clinical Trial Readiness
Australia's Noxopharm rises as novel cancer therapy shows potential
Brief: Noxopharm Says New Data Confirms Cancer-Fighting Potential
Brief: Noxopharm Appoints Dr Olivier Laczka As New CEO
Brief: Noxopharm Ltd Announces Resignation Of Chief Executive Officer